IL-7 SERUM LEVELS AND LYMPHOPENIA IN HEMODIALYSIS PATIENTS, NON-RESPONDERS TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY

被引：0
|
作者：
Costa, E. [1 ,2 ,5 ]
Lima, M. [3 ]
Rocha, S. [4 ,5 ]
Rocha-Pereira, P. [6 ]
Castro, E. [4 ,5 ]
Miranda, V. [7 ]
Faria, M. Sameiro [7 ]
Loureiro, A. [8 ]
Quintanilha, A. [5 ,9 ]
Belo, L. [4 ,5 ]
Santos-Silva, A. [4 ,5 ]
机构：
[1] Univ Porto, Serv Bioquimica, Fac Farm, Porto, Portugal
[2] IPB, Escols Sup Saude, Braganca, Portugal
[3] HGSA, Lab Citometria, Oporto, Portugal
[4] Fac Farm, Oporto, Portugal
[5] IBMC UP, Oporto, Portugal
[6] Univ Beira Interior, Covilha, Portugal
[7] Dinefro Dialises & Nefrol SA, Fresenius Med Ctr, Oporto, Portugal
[8] SA, Uninefro Sociedade Prestadora Ciudados Medicos &, Oporto, Portugal
[9] ICBAS, Oporto, Portugal
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0784
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [21] Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis
    Stefanidis, I
    Mertens, PR
    Wurth, P
    Bach, R
    Makropoulos, W
    Mann, H
    Heintz, B
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2001, 24 (06): : 367 - 373
  • [22] BODY MASS INDEX AND RESISTENCE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN MAINTENANCE HEMODIALYSIS PATIENTS
    do Sameiro-Faria, Maria
    Ribeiro, Sandra
    Kohlova, Michaela
    Rocha-Pereira, Petronila
    Fernandes, Joao
    Nascimento, Henrique
    Reis, Flavio
    Miranda, Vasco
    Bronze-da-Rocha, Elsa
    Quintanilha, Alexandre
    Costa, Elisio
    Belo, Luis
    Santos-Silva, Alice
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 488 - 488
  • [23] Gene Polymorphisms of IL-10 and MxA in Responders and Non-responders to Interferon Therapy in HCV Egyptian Patients Genotype 4
    Shaker, Olfat G.
    Abdel-Rahim, Mohamed T.
    Bayoumi, Salma T.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 617 - 625
  • [24] Gene Polymorphisms of IL-10 and MxA in Responders and Non-responders to Interferon Therapy in HCV Egyptian Patients Genotype 4
    Olfat G. Shaker
    Mohamed T. Abdel-Rahim
    Salma T. Bayoumi
    Cell Biochemistry and Biophysics, 2015, 71 : 617 - 625
  • [25] ERYTHROPOIETIC CHANGES IN CHRONIC-HEMODIALYSIS PATIENTS UNDERGOING RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY
    YOSHIDA, Y
    OHMORI, S
    TOHYAMA, K
    UCHINO, H
    SAWANISHI, K
    ITOH, M
    SOHMA, T
    KUZE, M
    ACTA HAEMATOLOGICA JAPONICA, 1988, 51 (06): : 1092 - 1096
  • [26] Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients
    Takayama, Kimihiro
    Nagai, Tetushi
    Kinugasa, Eriko
    Akizawa, Tadao
    Koshikawa, Syozou
    ASAIO Transactions, 1991, 37 (03):
  • [27] Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients
    do Sameiro-Faria, Maria
    Ribeiro, Sandra
    Rocha-Pereira, Petronila
    Fernandes, Joao
    Reis, Flavio
    Bronze-da-Rocha, Elsa
    Miranda, Vasco
    Quintanilha, Alexandre
    Costa, Elisio
    Belo, Luis
    Santos-Silva, Alice
    RENAL FAILURE, 2013, 35 (10) : 1392 - 1398
  • [28] An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin
    Markowitz, GS
    Kahn, GA
    Feingold, RE
    Coco, M
    Lynn, RI
    CLINICAL NEPHROLOGY, 1997, 48 (01) : 34 - 40
  • [29] Effect of biphenyl dimethyl dicaboxylate on serum levels of ALT in chronic hepatitis C patients including non-responders to prior interferon therapy
    Wakui, N
    Ishii, K
    Takamura, N
    Shinohara, M
    Shin, H
    Hata, S
    Kawafune, T
    Suginoto, M
    Sumino, Y
    GASTROENTEROLOGY, 2002, 123 (01) : 80 - 80
  • [30] LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN CHRONIC-HEMODIALYSIS PATIENTS
    DUFF, DR
    GOLPER, TA
    SLOAN, RS
    BRIER, ME
    ARONOFF, GR
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (01) : 60 - 64
12345